Allogeneic bone marrow derived mesenchymal stromal cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 16, 2021 (NCT04629833)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06075706 | Phase 2 | Oct 31, 2023 | Medac |
| NCT04629833 | Phase 3 | Aug 16, 2021 | Medac, Syneos Health |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medac | For profit | 2 | 2 | 2 | 2021 |
| Syneos Health | For profit | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1